Clinical Commentary2014 FIGO staging for ovarian, fallopian tube and peritoneal cancer
Section snippets
Conflict of interest statement
The authors declare that there are no conflicts of interest.
References (19)
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
Int J Gynecol Obstet
(2014)- et al.
Metastatic lymphnode number in epithelial ovarian carcinoma: does it have any clinical significance?
Gynecol Oncol
(2008) - et al.
The validity and significance of substage IIIC by node involvement in ovarian cancer: impact of nodal metastasis on patient survival
Gynecol Oncol
(1999) - et al.
Is it justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only?
Gynecol Oncol
(2006) - et al.
Ovarian cancer patients with “node positive-only” Stage IIIC disease have a more favorable outcome than Sage IIIA/B
Gynecol Oncol
(2007) - et al.
Surface epithelial stromal tumours: tumours of the ovary and peritoneum
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Virchows Arch
(2012)- et al.
Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer
J Pathol
(2001) - et al.
Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
J Clin Oncol
(2007)
There are more references available in the full text version of this article.
Cited by (265)
The diagnostic accuracy and prognostic implication of pelvic and peritoneal fluid cytology specimens in ovarian clear cell carcinoma
2024, Journal of the American Society of CytopathologyDevelopment of prediction model to estimate future risk of ovarian lesions: A multi-center retrospective study
2023, Preventive Medicine ReportsUnraveling the molecular mechanisms of lymph node metastasis in ovarian cancer: focus on MEOX1
2024, Journal of Ovarian Research
Copyright © 2014 Elsevier Inc. All rights reserved.